A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of TAK-925 Study in Sleep-Deprived Healthy Adults
Clinical trial NCT03522506 · COMPLETED
Trial details
- NCT number
- NCT03522506
- Sponsor
- Takeda
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-09
- Primary completion
- 2018-11-07
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.